Biagio Paolini

1.7k total citations
80 papers, 1.0k citations indexed

About

Biagio Paolini is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Biagio Paolini has authored 80 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 22 papers in Surgery and 19 papers in Cancer Research. Recurrent topics in Biagio Paolini's work include Endometrial and Cervical Cancer Treatments (14 papers), Breast Cancer Treatment Studies (12 papers) and Ovarian cancer diagnosis and treatment (11 papers). Biagio Paolini is often cited by papers focused on Endometrial and Cervical Cancer Treatments (14 papers), Breast Cancer Treatment Studies (12 papers) and Ovarian cancer diagnosis and treatment (11 papers). Biagio Paolini collaborates with scholars based in Italy, United States and Israel. Biagio Paolini's co-authors include Maurizio Colecchia, Andrea Necchi, Roberto Salvioni, Nicola Nicolai, Francesco Raspagliesi, Giorgio Bogani, Antonino Ditto, Elda Tagliabue, Vera Cappelletti and Roberto Agresti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Biagio Paolini

75 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Biagio Paolini Italy 20 325 318 305 213 188 80 1.0k
Vincenzo Fiorentino Italy 16 183 0.6× 211 0.7× 164 0.5× 125 0.6× 98 0.5× 74 717
Tilmann Lantzsch Germany 14 237 0.7× 172 0.5× 294 1.0× 101 0.5× 93 0.5× 26 819
Arnaud Da Cruz Paula United States 21 290 0.9× 221 0.7× 348 1.1× 210 1.0× 332 1.8× 74 1.2k
Michele De Nictolis Italy 19 333 1.0× 219 0.7× 326 1.1× 269 1.3× 481 2.6× 52 1.3k
Pier Selenica United States 21 312 1.0× 194 0.6× 424 1.4× 324 1.5× 288 1.5× 77 1.2k
Kiyong Na South Korea 18 175 0.5× 199 0.6× 157 0.5× 222 1.0× 260 1.4× 66 835
Maria L. Carcangiu United States 21 329 1.0× 277 0.9× 413 1.4× 138 0.6× 378 2.0× 32 1.4k
E. Kutarska Poland 12 274 0.8× 178 0.6× 440 1.4× 96 0.5× 285 1.5× 17 939
W. Weikel Germany 21 334 1.0× 152 0.5× 405 1.3× 130 0.6× 140 0.7× 49 1.3k
Huiying Piao United States 10 715 2.2× 125 0.4× 442 1.4× 198 0.9× 160 0.9× 10 1.2k

Countries citing papers authored by Biagio Paolini

Since Specialization
Citations

This map shows the geographic impact of Biagio Paolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biagio Paolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biagio Paolini more than expected).

Fields of papers citing papers by Biagio Paolini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biagio Paolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biagio Paolini. The network helps show where Biagio Paolini may publish in the future.

Co-authorship network of co-authors of Biagio Paolini

This figure shows the co-authorship network connecting the top 25 collaborators of Biagio Paolini. A scholar is included among the top collaborators of Biagio Paolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biagio Paolini. Biagio Paolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amant, Frédéric, Valentina Chiappa, Biagio Paolini, et al.. (2025). Malignant germ cells tumor of the ovary. Journal of Gynecologic Oncology. 36(3). e108–e108. 2 indexed citations
2.
Agresti, Roberto, Marco Sandri, Giuseppe Capri, et al.. (2024). Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial. British journal of surgery. 112(3). 2 indexed citations
3.
Cosimo, Serena Di, Sara Pizzamiglio, Chiara Maura Ciniselli, et al.. (2024). A gene expression-based classifier for HER2-low breast cancer. Scientific Reports. 14(1). 2628–2628.
4.
Ditto, Antonino, Fabio Martinelli, Umberto Leone Roberti Maggiore, et al.. (2024). Fertility-sparing treatment with conization versus radical hysterectomy in patients with early-stage cervical cancer: inverse propensity score weighted analysis. International Journal of Gynecological Cancer. 34(10). 1529–1535.
5.
Rybińska, Ilona, Sandra Romero‐Córdoba, Viola Regondi, et al.. (2024). SAA1‐dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressiveness. International Journal of Cancer. 154(10). 1842–1856. 7 indexed citations
6.
Rivoltini, Licia, Chiara Camisaschi, Giovanni Fucà, et al.. (2024). Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade. Scientific Reports. 14(1). 3379–3379. 6 indexed citations
7.
Minna, Emanuela, Biagio Paolini, Sonia Pagliardini, et al.. (2023). Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors. Frontiers in Endocrinology. 14. 1267499–1267499. 6 indexed citations
8.
Sanfilippo, Roberta, Marta Sbaraglia, Chiara Fabbroni, et al.. (2023). Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment. Clinical Cancer Research. 29(22). 4679–4684. 3 indexed citations
9.
Ditto, Antonino, Loris De Cecco, Biagio Paolini, et al.. (2021). Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessment. European Journal of Cancer. 161. 55–63. 4 indexed citations
10.
Rybińska, Ilona, Marco Sandri, Francesca Bianchi, et al.. (2020). Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment. Cells. 9(2). 434–434. 3 indexed citations
11.
Romero‐Córdoba, Sandra, E. Meneghini, Milena Sant, et al.. (2019). Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation. Cancers. 11(7). 911–911. 34 indexed citations
12.
Santis, Maria Carmen De, Eliana La Rocca, E. Meneghini, et al.. (2019). Axillary nodal involvement by primary tumor features in early breast cancer: an analysis of 2600 patients. Clinical & Translational Oncology. 22(5). 786–792. 1 indexed citations
13.
Renne, Salvatore Lorenzo, Silvia Redaelli, & Biagio Paolini. (2019). Cryoembedder, automatic processor/stainer, liquid nitrogen freezing, and manual staining for frozen section examination: A comparative study. Acta Histochemica. 121(6). 761–764. 4 indexed citations
14.
Triulzi, Tiziana, Viola Regondi, Loris De Cecco, et al.. (2018). Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit. British Journal of Cancer. 119(12). 1487–1494. 37 indexed citations
15.
Tessari, Anna, Lorenzo Pilla, Silvia Damian, et al.. (2018). Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?. The Breast. 42. 68–73. 27 indexed citations
16.
Galli, Giulia, Anna Tessari, Luca Porcu, et al.. (2017). Complete remission in metastatic breast cancer: expecting the unexpected—results of a cross-sectional study. Breast Cancer. 24(4). 635–641. 2 indexed citations
17.
Martelli, Gabriele, Rosalba Miceli, Secondo Folli, et al.. (2017). Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study. European Journal of Surgical Oncology. 43(11). 2012–2020. 19 indexed citations
18.
Necchi, Andrea, Domenico Magazzù, Andrea Anichini, et al.. (2016). An open-label, single-group, phase 2 study of brentuximab vedotin as salvage therapy for males with relapsed germ-cell tumors (GCT): Results at the end of first stage (FM12GCT01).. Journal of Clinical Oncology. 34(2_suppl). 480–480. 15 indexed citations
19.
Bregni, Giacomo, E. Meneghini, Giulia Galli, et al.. (2016). Breast cancer Ki67, tumor size and axillary nodes relationship: it's complicated. Annals of Oncology. 27. vi49–vi49. 1 indexed citations
20.
Callari, Maurizio, Matteo Dugo, G. Merlino, et al.. (2015). miR-30e* is an independent subtype-specific prognostic marker in breast cancer. British Journal of Cancer. 113(2). 290–298. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincenzo Fiorentino Breakdown of academic impact, for papers by Tilmann Lantzsch Breakdown of academic impact, for papers by Arnaud Da Cruz Paula Breakdown of academic impact, for papers by Michele De Nictolis Breakdown of academic impact, for papers by Pier Selenica Breakdown of academic impact, for papers by Kiyong Na Breakdown of academic impact, for papers by Maria L. Carcangiu Breakdown of academic impact, for papers by E. Kutarska Breakdown of academic impact, for papers by W. Weikel Breakdown of academic impact, for papers by Huiying Piao
Rankless by CCL
2026